跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZEULIDE DEPOT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZEULIDE DEPOT
Authorized
STANDARD
ZEULIDE DEPOT
Verity Pharmaceuticals Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8db713e783136d48
Company
Verity Pharmaceuticals Inc.
Type
Standard
Approval Details
Approval Id
8db713e783136d48
Drug Approval Canada Name
ZEULIDE DEPOT
Product Name
ZEULIDE DEPOT
Status
Marketed
Status Date
2019-10-08
Original Market Date
2019-10-08
Din
02462699
Drug Class
Human
Dosage Form
Powder For Suspension, Sustained-Release , Kit
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02AE02 LEUPRORELIN
Atc Name
l 02 ae 02
Aig Number
0116959005
Company Name
Verity Pharmaceuticals Inc.
Company Address
2560 Matheson Blvd. E., Suite 220, Mississauga, Ontario, Canada, L4W 4Y9
Company Detail Path
/organization/verity-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Verity Pharmaceuticals Inc.
Country Name
Canada
Province Name
British Columbia
City Name
vancouver,british columbia,country_ca
Address
2600-595 Burrard St
Active Ingredients
LEUPROLIDE ACETATE
22.5 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8db713e783136d48
Type
Standard
Back to Health Canada Approvals